November 10th. Pfizer and the German biotech company BioNTech announced on the 9th that their Coronavirus vaccine can prevent 90% of Coronavirus infections in large-scale trials.
After the news was sent out, it attracted the attention of the US media. US Vice President Pence said that the success of Pfizer’s Coronavirus vaccine development benefited from the support of a project under the US government. However, US media broke the news that the project did not cost a penny at all.
According to Bloomberg News on the 9th, after the good news about the vaccine was exposed, Pence posted on the social platform Twitter, “Thank President Trump for establishing a public-private partnership.
Pfizer announced that its Coronavirus vaccine test is effective and can prevent 90% of infections.” According to US media, as an official close to Trump, Pence is one of the members of the view that “the US government’s’speedy action’ plan to accelerate vaccine development”.
However, the US media changed the story and pointed out that “the truth is that Pfizer did not receive a penny from Operation Warp for R&D, clinical trials and production.
Instead, its partner BioNTech received funding from the German government.” According to an agreement in September, the German government allocated US$445 million to BioNTech to help accelerate the development and production of the Coronavirus vaccine.
BioNTech is praised by the outside world for its contribution to messenger ribonucleic acid-related technology, which promotes the human body to produce key proteins from viruses, thereby generating an immune response.
This biotechnology company has a history of cooperating with Pfizer to develop influenza vaccines. The two parties reached an agreement in March to jointly develop a Coronavirus vaccine.